BACKGROUND/AIM: @entity4150 ( @entity4150 ) promotes the survival and differentiation of sensory and sympathetic neurons. Several studies have found that certain neuropathological factors stimulate @entity4150 receptor expression and release the truncated @entity7169 (TNGFR) to biological fluids. The aim of this pilot study was to determine urine TNGFR levels in @entity1 with @entity303 and to verify whether TNGFR can be used as a biomarker of @entity303 . MATERIALS AND METHODS: Twelve @entity1 with @entity303 and 12 healthy individuals were asked to voluntarily participate in this study. Ages, sexes, and weights were matched. The first morning urine samples were collected and the concentrations of TNGFR in the urine samples were measured by fluoroimmunoassay. RESULTS: The mean levels of TNGFR in the urine samples of the healthy control subjects and the @entity1 with @entity303 were 164    23 and 341    66 ng / mg @entity1011 respectively. A positive relationship was found between the levels of TNGFR in different ages of both control and @entity1 subgroups. This is consistent with the previous observations that pathological condition may stimulate the @entity4150 receptor expression. CONCLUSION: These findings might be of assistance to evaluate the development of the @entity2414 associated with @entity195 and other age-associated diseases.

XXXX receptors in @entity303 .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity7169 :: ('4804', 'Gene') :: ['nerve growth factor receptor'] @entity303 :: ('MESH:D003704', 'Disease') :: ['dementia'] @entity4150 :: ('4803', 'Gene') :: ['Nerve growth factor', 'NGF'] @entity195 :: ('MESH:D000544', 'Disease') :: ['Alzheimer disease'] @entity1011 :: ('MESH:D003404', 'Chemical') :: ['creatinine'] @entity2414 :: ('MESH:D008569', 'Disease') :: ['memory loss']
@entity4150 :: (4803,Gene) :: ['Nerve growth factor']
